PREVENTION OF POSTOPERATIVE ANEMIA IN PATIENTS WITH TUBERCULOSIS

Abstract

The study included 28 patients with pulmonary tuberculosis and a possible postoperative hemoglobin level of less than 120 g/l. For the prevention of postoperative anemia it is used recombinant human erythropoietin alpha and iron (III) hydroxide sucrose complex. Hemoglobin levels were monitored for 4 weeks after surgery and it is estimated the need for blood transfusions. Use of recombinant human erythropoietin and iron sucrose in patients with pulmonary tuberculosis increases basic hematological parameters as compared with the control group, and reduces the risk of postoperative anemia.

References

  1. Использование рекомбинантного эритропоэтина для лечения анемии при туберкулёзе лёгких (пилотное исследование) / В.Г. Демихов [и др.] // Туберкулёз и болезни лёгких. - 2011. -№11. - С. 26-30.
  2. Способ прогнозирования развития послеоперационной анемии при плановых торакальных операциях у больных туберкулёзом / А.Н. Николаев [и др.] // В поисках оптимальных решений: новые идеи в хирургии и травматологии: сб. науч. тр. - Рязань, 2011. - С. 45-47.
  3. Faris P.M. The effects of recombinant human erythropoietin on perioperative transfusion requirements in patients having a major orthopaedic operation / P.M. Faris, M.A. Ritter, R.I. Abels; The American Erythropoietin Study Group // J Bone Joint Surg Am. - 1996. - Vol. 78. - Р. 62-72.
  4. Kumar A. Perioperative management of anemia: Limits of blood transfusion and alternatives to it / A. Kumar // Cleveland Clinic Journal of Medicine. - 2009. -№76 (Suppl 4). - P. 112-118.
  5. Laupacis A. Erythropoietin to minimize perioperative blood transfusion: a systematic review of randomized trials. The International Study of Peri-operative Transfusion (ISPOT) Investigators / A. Laupacis, D. Fergusson // Transfus Med. - 1998. - Vol. 8. - Р. 309-317.
  6. The Prevalence and Evolution of Anemia Associated wich Tuberculosis / W. Lee [et al.] // J. Korean. Med. Sci. - 2006. -Vol. 21. - P. 1028-1032.
  7. Preoperative administration of epoetin alfa to reduce transfusion requirements in elderly patients having primary total hip or knee reconstruction / R.A. Lofthouse [et al.] // J South Orthop Assoc. - 2000. -Vol. 9. - Р. 175-181.
  8. Effects of epoetin alfa on blood transfusions and postoperative recovery in orthopaedic surgery: the European Epoetin Alfa Surgery Trial (EEST) / E.W. Weber [et al.] // European Journal of Anaesthesiology. - 2005. - Vol. 22. - Р. 249-257.
  9. Spahn D.R. Eliminating blood transfusions. New aspects and perspectives / D.R. Spahn // Anesthesiology. - 2000. -Vol. 93. - Р. 242-255.
  10. Recombinant human erythropoietin administration in cardiac surgery / L. Yazicioglu [et al.] // J Thoac Cardiovasc Surg. - 2001. - Vol. 122. - Р. 741-745.

Copyright (c) 2014 Nikolaev A.N., Demikhov V.G., Dobin V.L., Inyakova N.V., Oskin D.N., Morshchakova E.F.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies